Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-02

Clinical Trial Update: Alpha Lipoic Acid for Treatment of Diabetic Neuropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating alpha-lipoic acid for treatment of diabetic neuropathy has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Universidad Popular Autónoma del Estado de Puebla | Conditions: Diabetic Neuropathy | Phase 4 | Status: COMPLETED | Results posted: 2016-03-02